SCHEMBL17059141

SCHEMBL17059141

CCC(=O)Nc1ccc(C(=O)NCCP(C)(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
KDM4E B2RXH2 1/20 0.53
HTT P42858 1/20 0.53
LMNA P02545 1/20 0.51
RAB9A P51151 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
MAPK1 P28482 1/20 0.48
POLB P06746 3/20 0.47
ADORA2A P29274 1/20 0.47
NPC1 O15118 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CYP2C19 P33261 1/20 0.47
NFKB1 P19838 1/20 0.47
KCNH2 Q12809 1/20 0.47
MAPT P10636 3/20 0.46
BLM P54132 2/20 0.46
CYP3A4 P08684 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18911291 0.85 PTPN1 (0.54) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL17151163 0.84 MEN1 (0.52) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL19147527 0.84 MEN1 (0.52) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL17232572 0.84 MEN1 (0.57) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL26197859 0.82 HDAC3 (0.46) MEN1KMT2AKDM4ELMNARAB9A
SCHEMBL11711682 0.78 L3MBTL1 (0.66) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL13652523 0.78 RAB9A (0.58) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL17072398 0.77 KMT2A (0.54) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL1230694 0.77 ALDH1A1 (0.77) MEN1KMT2AKDM4EHTTLMNA
SCHEMBL17151069 0.77 MEN1 (0.54) MEN1KMT2AKDM4EHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152274-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION HANGZHOU DAC BIOTECH CO., LTD. (CN) 2017-06-01 US disclosed
US-20150250896-A1 HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO A CELL BINDING MOLECULES HANGZHOU DAC BIOTECH CO., LTD. (CN) 2015-09-10 US disclosed
WO-2015127685-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION HANGZHOU DAC BIOTECH CO., LTD (CN) 2015-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152274-A1 CHARGED LINKERS AND THEIR USES FOR CONJUGATION PHOSPHO1, PCTP, CD2BP2 MEN1 848/4885KMT2A 2177/4885KDM4E 3504/4885
US-20150250896-A1 HYDROPHILIC LINKERS AND THEIR USES FOR CONJUGATION OF DRUGS TO A CELL BINDING MOLECULES CD44, EPCAM, ABCG2 MEN1 2818/4885KMT2A 3452/4885KDM4E 4270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.